Can a Non-Profit Drug Manufacturer Save our Healthcare System?

Midday on WNYC | Feb 5, 2018

Dan Liljenquist, former lawyer and state senator in Utah, now Director of Special Projects at Intermountain Healthcare, and Dr. Erin Fox, professor and expert on drug shortages at University of Utah, discuss a new initiative spearheaded by Intermountain Healthcare to create a non-profit that produces its own generic drugs. Several major not-for-profit hospitals are part of this initiative to stymie drug shortages and the high prices that come with them. Intermountain Healthcare plans to either contract manufacturing to an existing pharmaceutical company or get the Food and Drug Administration approval to manufacture medication itself. By cutting out the middleman, these hospitals intend to wrest control of drug availability and pricing from the hands of the free-market, thereby offering patients more affordable and reliable care.

This segment is guest hosted by Rebecca Carroll. 

WNYC Homepage - Top Stories

The unlikely organizers: Even NYC luxury renters are starting tenant associations

Why New York Bagel and Pizza Recipes May Change

The U.F.C. President, Dana White, on Donald Trump: “He’s Not a Racist”

Episode 4 of American Emergency; The Movement to Kill FEMA

YOU ARE ONLINE